1st Edition

Signal Analysis in Pharmacovigilance Principles and Processes

Edited By Anoop Kumar Copyright 2025
    304 Pages 44 Color & 12 B/W Illustrations
    by CRC Press

     This book provides detailed concept and information on principles and processes of signal analysis in pharmacovigilance along with case studies. It covers the fundamental concepts and principles of pharmacovigilance, emphasizing the need for robust signal detection and analysis methods. The book reviews the diverse array of databases and tools employed for signal detection, including electronic health records (EHRs), social media mining, claims data, and distributed data networks. In turn, the book discusses the application of molecular dynamics, molecular docking, and the use of the FDA Adverse Event Reporting System (FAERS) database in signal analysis. Towards the end, the book explores the identification, validation, and assessment of signals associated with vaccines. This book is useful for graduate, post graduate students of pharmaceutical sciences, and scientists in pharmacology research and drug development.

     

     Chapter 1: Introduction to Pharmacovigilance: Ensuring Medication Safety

     

    Sachin Kumar and Vikas Maharshi

     

    Chapter 2: Drug Safety Signal Detection and management in Pharmacovigilance

     

    Mira Desai

     

    Chapter 3: Databases and Tools for Signal Detection of Drugs in Post-Marketing Surveillance

    Jeesa George, Prizvan Lawrence Dsouza, Yalamanchili Jahnavi, Hemendra Singh, Pramod Kumar A

     

    Chapter 4: Role of Electronic medical records, Social Media, Claims data, distributed data networks in signal analysis

     

    Vandana Roy

     

    Chapter 5: Uncovering False Alarms: Examining Biases and Confounders in Disproportionality Analysis

     

    Lipin Lukose, Mansi Pawar, Aina M Shaju, Gouri Nair, Subeesh K Viswam

     

    Chapter 6: Role of Medical Coding in Signal Detection

     

    Dipika Bansal, Beema T Yoosuf, Muhammed Favas KT

     

    Chapter 7: Regulatory Aspects in Signal Detection and Assessment

     

    James Buchanan

     

    Chapter 8: Disproportionality Methods for Signal Detection in Pharmacovigilance

     

    Krishna Undela and Christy Thomas

     

    Chapter 9: Bayesian methods of signal detection

     

    Dipika Bansal, Muhammed Favas KT, Beema T Yoosuf

     

    Chapter 10: Subgroup and sensitivity analysis

     

    Faiza Javed and Anoop Kumar

     

    Chapter 11: Causality Assessment of ICSRs

     

    V. Kalaiselvan and Rishi Kumar

     

    Chapter 12: Signal Analysis of Drug-Drug Interaction Using Spontaneous Reporting Method

     

    Rima Singh, Ruchika Sharma, Deepti Pandita, Anoop Kumar

     

    Chapter 13: Use of network pharmacological approaches in signal analysis

     

    Vipin Bhati, Ruchika Sharma, Deepti Pandita, and Anoop Kumar

     

    Chapter 14: Docking studies in signal analysis: An overview

     

    Kumari Kala Sah, Ruchika sharma, S.latha and Anoop Kumar

     

    Chapter 15: Molecular Dynamics simulations in signal validation

     

    Debanjan Dey and Anoop Kumar

     

    Chapter 16: Identification and validation of novel signal of drugs using FAERS database: A case study

     

    Sweta Roy, Vipin Bhati, Ruchika Sharma, Deepti Pandita, and Anoop Kumar

     

    Chapter 17: Molecular docking and molecular dynamics in Signal analysis: A case study

     

    Sweta Roy, Ruchika Sharma, and Anoop Kumar

     

    Chapter 18: Available Databases and Tools for signal detection of vaccines

     

    Sachin Kumar and Vikas Maharshi

     

    Chapter 19: Identification and validation of signals associated with vaccines

     

    Juny Sebastian

     

    Chapter 20: Neurological and behaviour alterations with COVID-19 vaccines using Vaccine Adverse Event Reporting System (VAERS): A Retrospective study

     

    Amir, Saquib Haider and Anoop Kumar

     

    Chapter 21: Pharmacovigilance based drug repurposing via inverse signals

     

    Simran Ohra and Anoop Kumar

     

    Chapter 22: Prospective role of preclinical experimentation in validating the safety signals

     

    Chandragouda Raosaheb Patil, Chandrakant Gawli and Shwetank Bhat

     

    Chapter 23: Role of Artificial Intelligence in Signal Detection

     

    Rethesh Kiran, Priyanka, Jeesa George, Pramod Kumar A, Prizvan Lawrence Dsouza

    Biography

    Dr. Anoop Kumar is currently working as Assistant Professor in Department of Pharmacology, Delhi Pharmaceutical Sciences & Research University (DPSRU), Govt. of NCT of Delhi, New Delhi, India. He has earlier served as Assistant Professor in the Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli. He has also worked as Associate Professor and Head in the Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab. He has also worked as Research Scientist in Translational Health Science Institute (THSTI), Faridabad and Medical Affairs and Clinical Research Department of Sun Pharmaceutical Limited, Gurugram, India.

    He has authored more than 100 research and review articles as well as 20 book chapters in International Journals and Publishers of repute. His current h-index is 25, i10 index 53 with citations of 2132. He is also an author of 03 books. He has also filed 05 Indian patents. He has received research grants from the Indian Government (DST SERB, ICMR, and IIT Delhi). He was receipt of DST INSPIRE Fellow (2012-2016), as well as receipt of Distinguished and Notable Researcher Award (2021-2022). He has also been included in the top 2% lists of scientists released by Stanford. Currently, he is also working as member secretary of human ethics committee approved by Central Drugs Standard Control Organisation (CDSCO), Ministry of Health & Family Welfare, Government of India and Treasure of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) India Chapter. He is also an expert member in Board of studies of various reputed Universities. He is life time members of various professional societies like Indian Pharmacological Society (IPS), Association of Pharmaceutical Teachers of India (APTI), and Society for Alternatives to Animal Experiments (SAAE), India. He has also worked as member secretary and animal house In charge approved by Committee for Control and Supervision of Experiments on Animals (CCSEA), Government of India. His research interests are drug repurposing using computational and experimental studies, Meta-analysis, Signal analysis in Pharmacovigilance, Pharmacoeconomic studies.